HP
BIIB icon

HealthInvest Partners’s Biogen BIIB Stock Holding History

HealthInvest Partners’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.6M Buy
+62,781
New +$12M 3.65% 8
2022
Q3 		– Sell
-16,000
Closed -$3.26M – 11
2022
Q2 		$3.26M Sell
16,000
-12,000
-43% -$2.45M 7.52% 7
2022
Q1 		$5.9M Buy
+28,000
New +$6.09M 9.39% 4
2017
Q4 		$2.68M Sell
8,400
-12,000
-59% -$3.85M 5.65% 14
2017
Q3 		$6.39M Sell
20,400
-4,600
-18% -$1.36M 7.46% 9
2017
Q2 		$6.78M Buy
+25,000
New +$6.61M 8.46% 9

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

HealthInvest Partners's BIIB Position: Q2 2026 in Review

HealthInvest Partners opened a new position in Biogen (BIIB) in Q2 2026: 62,781 shares worth $13.6M. The stake represents 3.65% of the portfolio and ranks #8 among its holdings. This is a return to the name: HealthInvest Partners previously reported a position in BIIB as recently as Q2 2022.

HealthInvest Partners first reported a position in BIIB in Q2 2017 and has held it in 6 quarters since. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • HealthInvest Partners held 62,781 shares of Biogen worth $13.6M as of Q2 2026.
  • Biogen was a new HealthInvest Partners position in Q2 2026.
  • Biogen made up 3.65% of HealthInvest Partners's portfolio in Q2 2026, its #8 holding.
  • HealthInvest Partners first reported a position in Biogen in Q2 2017 and has held it in 6 quarters since.
  • 1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on HealthInvest Partners's 13F filing for Q2 2026, filed 24 Jul 2026.